Quick Answer
TELA Bio, Inc. reported Gross Profit of $54.34 million for fiscal year 2025.
TELA Bio, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $54.34M | +16.9% |
| 2024 | $46.49M | +15.9% |
| 2023 | $40.11M | +48.3% |
| 2022 | $27.04M | +43.8% |
| 2021 | $18.81M | +67.5% |
| 2020 | $11.23M | +21.2% |
| 2019 | $9.27M | +215.2% |
| 2018 | $2.94M | +16.2% |
| 2017 | $2.53M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.97M | +8.6% | -1.0% |
| June 30, 2025 | $14.11M | +27.4% | +12.7% |
| March 31, 2025 | $12.51M | +10.4% | -2.7% |
| September 30, 2024 | $12.86M | +23.8% | +16.1% |
| June 30, 2024 | $11.07M | +8.5% | -2.3% |
| March 31, 2024 | $11.34M | +43.5% | +9.1% |
| September 30, 2023 | $10.39M | +41.9% | +1.8% |
| June 30, 2023 | $10.20M | +55.7% | +29.2% |
- TELA Bio, Inc. showed an increase of +16.9% in Gross Profit compared to the prior fiscal year.
- Over the 2017–2025 period, TELA Bio, Inc.’s gross profit has grown by 2046.2% (from $2.53 million to $54.34 million).
- The most recent figure is from TELA Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: